Related Experiment Video
Updated: Sep 29, 2026

Measurement of Endothelium-Dependent Vasorelaxation in the Mouse Thoracic Aorta Using Tensometric Small Volume Chamber Myography
Published on: August 12, 2022
Diastolic subclinical primary alterations in Marfan syndrome and Marfan-related disorders
Maria Cristinna Porciani1, Letzia Giurlani, Andrea Chelucci
1Dipartimento di Area Critica Medico Chirurgica, University of Florence, Italy. c.porciani@dfc.unifi.it
Background:
The extracellular matrix tissue of the myocardium importantly contributes to left ventricular (LV) performance. Inherited connective tissue disorders related to the FBN1 gene could involve cardiac interstitium resulting in functional abnormalities.
Hypothesis:
To disclose a primary involvement of myocardium, LV function was studied in 28 patients affected by Marfan syndrome or Marfan-related disorders: 20 Marfan and 8 MASS (Mitral valve prolapse, Myopia, Aortic dilatation, Skeletal involvement, Skin striae) and in 28 healthy, age and gender-matched controls. No valvular regurgitation or any other cardiac alterations were present.
Methods:
Echocardiographic study was performed to investigate LV systolic and diastolic function.
Results:
No statistically significant differences were observed between patients and the control group in LV dimensions, systolic function parameters (ejection and shortening fraction), and some diastolic function parameters (E peak, A peak, E/A), while statistically significant differences were found between patients and the control group in LV mass (128.7 +/- 46.6 vs. 83.7 +/- 14.5 g/m2, p<0.008), in isovolumic relaxation time (102.0 +/- 24.0 vs. 80.1 +/- 11.2 ms, p<0.016), and in deceleration time of the E wave (127.5 +/- 19.3 vs. 208.6 +/- 24.5 ms, p<0.001) and the A wave (66.4 +/- 8.2 vs. 87.5 +/- 23.4 ms, p <0.008).
Conclusions:
These data show an unusual pattern of transmitral diastolic flow in which a decreased ventricular compliance and reduced myocardial relaxation coexist. Thus, in Marfan syndrome and in Marfan-related disorders, subclinical diastolic alterations are present independent of valvular disease and might represent an early marker of primary myocardial involvement.
Insights
Marfan syndrome and related disorders cause subclinical diastolic dysfunction in the heart, indicated by altered transmitral flow patterns. These changes suggest early primary myocardial involvement, even without valve issues.
Area of Science:
- Cardiology
- Genetics
- Biomedical Engineering
Background:
- The heart's extracellular matrix is crucial for left ventricular (LV) performance.
- FBN1 gene disorders can affect the cardiac interstitium, leading to functional abnormalities.
Purpose of the Study:
- To investigate primary myocardial involvement in Marfan syndrome and related disorders.
- To assess left ventricular (LV) function in patients with Marfan syndrome and MASS phenotypes compared to controls.
Main Methods:
- Echocardiography was used to evaluate LV systolic and diastolic function.
- Study included 28 patients with Marfan syndrome or related disorders and 28 healthy controls.
Main Results:
- No significant differences in LV dimensions or systolic function were found between groups.
- Patients showed increased LV mass, prolonged isovolumic relaxation time, and altered E and A wave deceleration times.
Conclusions:
- Marfan syndrome patients exhibit an unusual diastolic flow pattern with decreased ventricular compliance and impaired relaxation.
- Subclinical diastolic alterations in Marfan syndrome may serve as an early marker of primary myocardial involvement, independent of valvular disease.
Related Concept Videos
Aneurysm I: Introduction
Mitral Valve Prolapse I: Introduction
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Regurgitation I: Introduction

